1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Brain Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsuta, K; Nakanishi, H; Shirakawa, K; Takagi, K; Tamura, A; Yoshida, K | 1 |
1 other study(ies) available for 1-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline and Brain Diseases
Article | Year |
---|---|
The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Topics: Animals; Brain Diseases; Brain Ischemia; Dizocilpine Maleate; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tetrahydroisoquinolines | 1995 |